Is United Therapeutics Corporation (UTHR) a Smart Choice in Biotechnology Thursday?

Thursday, May 19, 2022 01:36 PM | InvestorsObserver Analysts

Mentioned in this article

Is United Therapeutics Corporation (UTHR) a Smart Choice in Biotechnology Thursday?

A rating of 79 puts United Therapeutics Corporation (UTHR) near the top of the Biotechnology industry according to InvestorsObserver. United Therapeutics Corporation's score of 79 means it scores higher than 79% of stocks in the industry. United Therapeutics Corporation also received an overall rating of 58, putting it above 58% of all stocks. Biotechnology is ranked 70 out of the 148 industries.

UTHR has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on UTHR!

See Full UTHR Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 58 would rank higher than 58 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With United Therapeutics Corporation Stock Today?

United Therapeutics Corporation (UTHR) stock is up 0.69% while the S&P 500 is down -0.36% as of 1:35 PM on Thursday, May 19. UTHR is up $1.28 from the previous closing price of $185.38 on volume of 119,666 shares. Over the past year the S&P 500 is lower by -5.01% while UTHR is down -1.66%. UTHR earned $14.44 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 12.93. Click Here to get the full Stock Report for United Therapeutics Corporation stock.